Galena Biopharma In The News
- Galena Biopharma Enters Into Definitive Agreement to License U.S. Rights for Zuplenz(R) (ondansetron) Oral Soluble Film
- Galena Biopharma Receives Notice of Allowance of Broad U.S. Patent for NeuVax(TM) (nelipepimut-S)
- Galena Biopharma to Present at the 9th Annual JMP Securities Healthcare Conference
- Galena Biopharma Completes Enrollment in GALE-301 Phase 2a Clinical Trial in Ovarian and Endometrial Cancers
Galena is committed to ensuring eligible patients have access to our products. Learn more at GalenaPatientServices.com.